Sort
50,496 grants matching “lung cancer”
The B7x pathways in the tumor microenvironment
$398,901Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2021 · CA
Tumor Suppressor Qualities and Mechanisms of LZAP Activity
$398,899Wendell G Yarbrough · Yale University · R01 · FY2013 · DE
Regulation of KRAS plasma membrane targeting by defined glycosphingolipids.
$398,862John F Hancock · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · GM
Incident cancer studies in a unique arsenic-exposed area of Chile
$398,857Craig M Steinmaus · University Of California Berkeley · R01 · FY2007 · ES
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer
$398,856Yevgeniy Vinogradskiy · University Of Colorado Denver · R01 · FY2020 · CA
Circle RNA Regulation of Lung Cancer Metastasis
$398,845Chad V Pecot · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
Occupational and Environmental Determinants of Cancer among Women and Minorities
$398,807Jonathan Hofmann · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
Decoding and targeting saccharopine pathway in cancer metastasis
$398,797Sumin Kang · Emory University · R01 · FY2024 · CA
Development of a New Strategy to Treat Locally Advanced Pancreatic Cancer
$398,775Scott Andrew Gerber · University Of Rochester · R01 · FY2019 · CA
OncoPath: Intelligent Clinical Pathway Decision Support Tool for Pre-Authorization Documentation in Non-Small Cell Lung Cancer Treatment
$398,721Sharon Hensley Alford · Vizlitics Inc. · R43 · FY2021 · CA
A novel monobody-drug conjugate to treat mutant KRas pancreatic cancer.
$398,715Craig Patrick Ramirez · Tezcat Laboratories Llc · R41 · FY2021 · CA
Epigenetic Control of SMC Transitions to a Multi-Potential Stem Cell-Like State
$398,713Gary K Owens · University Of Virginia · R01 · FY2014 · HL
Mechanisms of linkage of stem and invasive phenotypes during metastatic colonization
$398,713Maja Hrzenjak Oktay · Albert Einstein College Of Medicine · P01 · FY2022 · CA
Pathophysiology Core
$398,710Rubin M Tuder · University Of Colorado Denver · P01 · FY2020 · HL
Immunoglobulin-Driven Activation of the Complement Cascade is a Critical Determinant of PAH Initiation and Progression
$398,709Kurt R Stenmark · University Of Colorado Denver · P01 · FY2020 · HL
Role of beta-arrestins in chemokine receptor signaling
$398,687Adriano Marchese · Medical College Of Wisconsin · R01 · FY2021 · GM
Organic cation transporter 2 and cisplatin nephrotoxicity
$398,671Alexander Sparreboom · St. Jude Children'S Research Hospital · R01 · FY2011 · CA
Diagnosis of IM Nodal Metastases in Breast Cancer
$398,602University Of Washington · R01 · FY2003 · CA
Project 2: Near-Infrared Targeted Tracers for Intraoperative Identification of NSCLC
$398,594Philip Stewart Low · University Of Pennsylvania · P01 · FY2024 · CA
Organic cation transporter 2 and cisplatin nephrotoxicity
$398,576Alexander Sparreboom · St. Jude Children'S Research Hospital · R01 · FY2012 · CA
Cancer Genetic Markers of Susceptibility
$398,548Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2009 · CA
Tumor microenvironment at single cell level in black and white NSCLC patients
$398,545Wei Zhang · Wake Forest University Health Sciences · R21 · FY2020 · CA
C16-Ceramide Nano-Liposomes Reverse Multi-Drug Resistance
$398,509Richard N Kolesnick · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Dissecting KRAS oncoprotein signaling with allele specific inhibitors
$398,509Piro Lito · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Ventricular Remodeling in the Adapted Heart
$398,449Nilanjana Maulik · University Of Connecticut Sch Of Med/Dnt · R01 · FY2010 · HL